* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:AS00 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, European Medical Solutions's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
European Medical Solutions Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, European Medical Solutions's Days Payable distribution charts can be found below:
* The bar in red indicates where European Medical Solutions's Days Payable falls into.
European Medical Solutions Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
European Medical Solutions (STU:AS00) has a Days Payable of 135.13 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on European Medical Solutions and its competitors. This is 26% above median its historical median of 107.03. Over the past decade, European Medical Solutions' Days Payable has ranged from 80.80 to 134.42. According to the industry distribution chart, European Medical Solutions ranks #319 out of 705 companies in the Biotechnology industry, placing it in the top 45.2%.
Is European Medical Solutions' Days Payable too high?
European Medical Solutions' current Days Payable of 135.13 is 26% above median its 10-year median of 107.03. Over the past 10 years, this metric has ranged from a low of 80.80 to a high of 134.42. The Biotechnology industry median Days Payable is 113.36. European Medical Solutions' value of 135.13 is 19.2% above this industry median. Based on the distribution chart, European Medical Solutions ranks #319 out of 705 companies in the Biotechnology industry, which is above the industry midpoint. Overall, European Medical Solutions has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does European Medical Solutions' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, European Medical Solutions ranks #319 out of 705 companies for Days Payable. This puts European Medical Solutions in the upper half of its industry. The industry median Days Payable is 113.36. European Medical Solutions' value of 135.13 is 19.2% above this benchmark. Historically, European Medical Solutions' own Days Payable has ranged from 80.80 to 134.42 over the past decade. While the company's 10-year median is 107.03 vs. the industry median of 113.36, European Medical Solutions has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.36, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. European Medical Solutions's current Days Payable of 135.13 is 19.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on European Medical Solutions and its competitors. For the Biotechnology industry, the median Days Payable is 113.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. European Medical Solutions's current Days Payable is 135.13, which is 26% above median its own 10-year median of 107.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Medical Solutions stock overvalued right now?
European Medical Solutions (STU:AS00) has a current Days Payable of 135.13. The stock's GF Value™ is €8.11, compared to a current price of €4.82 — trading 40.6% below its estimated fair value. The current Days Payable is 135.13, which is 26% above median its 10-year median of 107.03 and 19.2% above the Biotechnology industry median of 113.36. European Medical Solutions' overall GF Score™ is 47/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For European Medical Solutions (STU:AS00), the current Days Payable is 135.13 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is European Medical Solutions (STU:AS00) Overvalued in 2026?
Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued.
The current stock price of €4.82 is trading 40.6% below its estimated GF Value™ of €8.11.
Key valuation signals for STU:AS00:
Days Payable: 135.13 (26% above median its 10-year median of 107.03)
GF Value™: €8.11 vs. price of €4.82 (40.6% below fair value)
Industry Position: 19.2% above the Biotechnology median (#319 of 705)
No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
47GF Score
Get the complete analysis for STU:AS00
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:AS00 has been successfully added to your 
